Location: Home
  • search
  • go
  • Relate News
  • 9/28/2021I-Mab's Chinese IND Accepted for P2 Trial of Enoblituzumab in Combo wi...
  • 9/27/2021Innovent and UNION Therapeutics Enter License Deal for Next-generation...
  • 9/27/2021Transcenta Cleared for Chinese IND of Anti-sclerostin mAb TST002
  • 9/24/2021Akeso's Chinese NDA for Cadonilimab Accepted by NMPA
  • 9/24/2021Review of Performance Results of Listed Chinese Pharma Companies H1/20...
  • 9/24/2021Review of R&D Investments of Selected Listed Chinese Pharma Companies ...
  • 9/24/2021Snapshot of BMI System Financial Performance in H1/2021
  • 9/24/2021Recent Executive Moves
  • 9/23/2021Sihuan/Xuanzhu and SignalChem Announce Licensing Deal for SLC-391 in G...
  • 9/23/2021Guangzhou Pharma Eyes Public Listing of Subsidiaries
  • 9/23/2021Cytiva Triples Bioprocessing Single-Use Consumables Capacity in China
  • 9/23/2021Innovent's sNDA for Sintilimab in Combo with Chemotherapy as First-L...
  • 9/23/2021Prevalence of Depressive Disorders and Treatment in China: A Cross-Sec...
  • 9/22/2021NMPA Issues Q2/2021 Drug Regulatory Statistics Report
  • 9/22/2021China-based CMS Joins BaseLaunch as Latest Partner
  • 9/17/2021Celsion and Hainan Poly Pharm Sign Agreement to Manufacture Celsion's ...
  • 9/17/2021Recent Executive Moves
  • 9/16/2021Luye Pharma Ties Up with ESTEVE for Its Alzheimer's Patch in Spain
  • 9/16/2021Everest Medicines, Sinovent and SinoMab Enter Licensing Deal for Novel...
  • 9/16/2021AstraZeneca, Daiichi Sankyo Begin New Gastric Cancer Enhertu Trial in ...
  • 9/16/2021Asymchem and LaNova Medicines Form Partnership, Expanding Biological C...
  • 9/16/2021Chinese Pursuit of Avigan Patent Faces Pushback in Japan
  • 9/16/2021Innovent Releases Phase 2 Results of Pemigatinib in Chinese Patients w...
  • 9/15/2021Hua Medicine and Sinopharm Enter Supply Chain Strategic Cooperation
  • 9/15/2021NMPA Holds the 6th China-ASEAN Summit for Drug Development and Coopera...
  • 9/15/2021CStone Secures China NMPA IND Approval for CS2006/NM21-1480
  • 9/15/2021Zai Lab Granted Chinese Breakthrough Therapy Designation for Bemarituz...
  • 9/15/2021BeiGene Announces U.S. FDA Acceptance of BLA for Tislelizumab in ESCC
  • 9/15/2021China to Improve Medical Insurance System in the 14th FYP to Better Me...
  • 9/15/2021FiercePharma: BeiGene's Brukinsa Turns Up Heat against Imbruvica with ...
  • Page:58/333 Total number of articles:9989: [First][<<] [56] [57] [58] [59] [60] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group